Gene · 9821
NIH grants1,585
NIH grants whose papers are about the gene, through NIH's grant-paper links.
661 to 680 of 1,585
Download this page as JSON| Grant | Title | RB1CC1 papers | Newest fiscal year |
|---|---|---|---|
| K22HL139921 | Identification and Characterization of Novel Metabolic Regulators in Mouse and Human Liver | 1 | 2020 |
| P01AG014930 | Mitochondrial and Metabolic Dysfunction in Age-related Neurodegeneration | 1 | 2020 |
| P30AG028383 | University of Kentucky Alzheimer's Disease Core Center | 1 | 2020 |
| P30AG053760 | Michigan Alzheimer's Disease Core Center | 1 | 2020 |
| P30ES000260 | Research in Environmental Health Sciences | 1 | 2020 |
| R01AG050660 | Discovering the molecular mechanisms that determine replicative lifespan | 1 | 2020 |
| R01AI117864 | Identification of HIV latency biomarkers with a dual fluorescence reporter HIV | 1 | 2020 |
| R01AI122176 | Endocytic Control of Autophagosome Formation in Lupus T cells | 1 | 2020 |
| R01AI123221 | Molecular Regulation of Long-term Immune Memory | 1 | 2020 |
| R01AR067766 | Regulation of Mitsugumin 29 expression in muscle physiology and diseases | 1 | 2020 |
| R01CA193970 | Promoting Bim-driven apoptosis through MAPK inhibition: A therapeutic strategy in advanced melanoma | 1 | 2020 |
| R01CA197098 | Roles of miR-129 in colorecal cancer | 1 | 2020 |
| R01CA200232 | Targeting Prolyl Peptidases in Tamoxifen Resistant Breast Cancer | 1 | 2020 |
| R01CA200651 | Targeting the APC/Cdc20 E3 ubiquitin ligase for chemoradiation sensitization | 1 | 2020 |
| R01CA221290 | Metabolic reprogramming of Tregs in tumor immunity | 1 | 2020 |
| R01DC015111 | Deciphering the Usher I protein interactome using a genetic approach | 1 | 2020 |
| R01DK083355 | Mechanisms of bile duct reprogramming | 1 | 2020 |
| R01DK111436 | Epigenomic Remodeling of Metabolism by Exercise through AP-1 | 1 | 2020 |
| R01EY013434 | Approaches to enhance lysosomal function in RPE cells | 1 | 2020 |
| R01EY027733 | Lysosomal Enzymes in Outflow Pathway Physiology and Pathophysiology | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9821/grants?page=34